1. Home
  2. CHSCN vs FBIOP Comparison

CHSCN vs FBIOP Comparison

Compare CHSCN & FBIOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CHS Inc Preferred Class B Series 2 Reset Rate

CHSCN

CHS Inc Preferred Class B Series 2 Reset Rate

N/A

Current Price

$25.35

Market Cap

0.0

Sector

Industrials

ML Signal

N/A

Logo Fortress Biotech Inc.

FBIOP

Fortress Biotech Inc.

HOLD

Current Price

$12.64

Market Cap

0.0

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHSCN
FBIOP
Founded
N/A
N/A
Country
United States
United States
Employees
N/A
101
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CHSCN
FBIOP
Price
$25.35
$12.64
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
N/A
N/A
Earning Date
N/A
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
N/A
N/A
52 Week High
N/A
N/A

Technical Indicators

Market Signals
Indicator
CHSCN
FBIOP
Relative Strength Index (RSI) 57.28 76.16
Support Level $25.18 $11.76
Resistance Level $25.44 $12.98
Average True Range (ATR) 0.15 0.78
MACD 0.02 0.11
Stochastic Oscillator 61.53 91.88

Price Performance

Historical Comparison
CHSCN
FBIOP

About CHSCN CHS Inc Preferred Class B Series 2 Reset Rate

CHS Inc is an integrated agricultural enterprise, that provides grain, food, and energy resources to businesses and consumers. Its Energy segment produces and provides wholesale distribution of petroleum products and transportation of those products. Its Ag segment, which is the key revenue driver, purchases and processes or resells grains and oilseeds; serves as a wholesaler and retailer of crop inputs; produces and markets ethanol. Its Nitrogen Production segment consists of equity method investment in CF Nitrogen, which entitles the purchase of up to a specified quantity of granular urea and UAN annually from CF Nitrogen. Geographically, the company derives maximum revenue from North America and the rest from South America, Asia Pacific, Europe, Middle East, and Africa (EMEA).

About FBIOP Fortress Biotech Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.

Share on Social Networks: